Korro Bio (KRRO) Total Debt (2018 - 2023)
Korro Bio's (KRRO) quarterly Total Debt came in at $11.7 million in Q1 2023, down 22.22% YoY from $15.0 million in Q1 2022, and down 17.65% on a QoQ basis from $14.2 million in Q4 2022.
Korro Bio (KRRO) Total Debt (2018 - 2023) Analysis & Trends
Korro Bio (KRRO) has 6 years of Total Debt data on file, last reported at $11.7 million in Q1 2023.
- Quarterly Total Debt fell 22.22% year-over-year to $11.7 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $11.7 million (down 22.22% YoY) and the FY2022 annual result came in at $14.2 million, down 5.55% from the prior year.
- Total Debt declined to $11.7 million in Q1 2023, from $14.2 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $15.0 million in Q4 2020 to a low of $180000.0 in Q4 2019.
- A 5-year average of $12.2 million and a median of $15.0 million in 2020 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2019 — Total Debt plunged 48.42% — and 2020, when it jumped 8233.33%.
- Tracing KRRO's Total Debt over 5 years: stood at $180000.0 in 2019, then jumped by 8233.33% to $15.0 million in 2020, then changed by 0.0% to $15.0 million in 2021, then retreated by 5.55% to $14.2 million in 2022, then dropped by 17.65% to $11.7 million in 2023.
- The last three Total Debt figures came in at $11.7 million (Q1 2023), $14.2 million (Q4 2022), and $15.0 million (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Korro Bio | 228.60 Mn | 113.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 11.67 Mn |
| Dec 31, 2022 | 14.17 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 15.00 Mn |
| Mar 31, 2022 | 15.00 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 15.00 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Mar 31, 2021 | 15.00 Mn |
| Dec 31, 2020 | 15.00 Mn |
| Dec 31, 2019 | 180,000.00 |
| Sep 30, 2019 | 222,000.00 |
| Dec 31, 2018 | 349,000.00 |